Document is current
Any future updates will be listed below
-
Authors
Bloem, M. https://orcid.org/0000-0001-9843-4285
de Meza, M. M.
van den Eertwegh, A. J. M.
Aarts, M. J. B.
van den Berkmortel, F. W. P. J.
Blank, C. U. https://orcid.org/0000-0002-7945-5846
Blokx, W. A. M.
Boers-Sonderen, M. J.
Bonenkamp, J. J.
Boreel, C. D. M.
de Groot, J. W. B.
Haanen, J. B. A. G.
Hospers, G. A. P. https://orcid.org/0000-0002-3047-7892
Kapiteijn, E. https://orcid.org/0000-0002-4814-6426
van Not, O. J.
Piersma, D.
Rikhof, B.
Stevense-den Boer, A. M.
van der Veldt, A. A. M. https://orcid.org/0000-0003-0446-1907
Vreugdenhil, G.
Suijkerbuijk, K. P. M. https://orcid.org/0000-0003-3604-5430
Wouters, M. W. J. M.
- License Information
-
More Information
Article History
Received: 13 January 2025
Revised: 14 March 2025
Accepted: 4 April 2025
First Online: 15 April 2025
Competing interests
: AE participates in the Advisory Boards of Bristol-Myers Squibb, MSD Oncology, Ipsen, Pierre Fabre, Janssen Cilag BV. All fees were paid to the institution. GH has received grants from Seerave and Bristol-Myers Squibb, paid to the institution. GH participates in the Advisory Boards of Bristol-Myers Squibb, Roche, MSD, Novartis, Sanofi, Pierre Fabre, and Amgen. All fees were paid to the institution. KS has received grants from AbbVie, Novartis, Genmab, Philips, and Pierre Fabre, and participates in the Advisory Boards of AbbVie and Sairopa. All fees were paid to the institution. MA has received personal payment for the GUCS review; a national, online presentation “Highlight medical oncologie GU” in the Netherlands. MA received personal support from ASCO (2022) to attend the meeting. MA participated in the Advisory Boards of Amgen, Bristol Myers Squibb, Novartis, MSD-Merck, Merck-Pfizer, Pierre Fabre, Sanofi, Astellas, Bayer, and received a research grant from Merck-Pfizer. All fees were paid personally. AV participates in the Advisory Boards of Bristol-Myers Squibb, MSD, Ipsen, Eisai, Roche, Novartus, Sanofi, and Pfizer. All fees were paid to the institution. DP has received payment from Novartis for education about melanoma for new employees and from BMS for case writing for educational purposes. DP participates in the Advisory Boards of Peirre Fabre.
: The medical ethical committee considered the DMTR not subject to the Medical Research Involving Human Subjects Act under Dutch regulations since all data is anonymized, eliminating the need for informed consent. The study was performed in accordance with the Declaration of Helsinki.
